DCGO DocGo Inc.
FY2025 10-K
DocGo Inc. (DCGO) filed its fiscal year 2025 10-K annual report with the SEC on Mar 16, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: Vertically integrated mobile healthcare platform combining in-home medical services, virtual care, and ambulance transport across US and UK
- • New in 2025: Acquisition of 50-state virtual care network with white-label telehealth, plus northeast mobile phlebotomy provider
Management Discussion & Analysis
- • Revenue $322.2M in 2025, down 47.7% YoY from $616.6M in 2024, due to 71.3% decline in Mobile Health to $121.4M, Transportation up 3.8% to $200.8M
- • Operating margin -55.3% in 2025 vs 4.7% in 2024; cost of revenues ratio 69.4% vs 65.3%; operating expenses 85.9% of revenue vs 30.0% in 2024, driven by impairments
Risk Factors
- • Regulatory risk: U.S. Department of Justice and Federal Trade Commission reviews could delay or block acquisitions, impacting DocGo’s growth strategy
- • Geopolitical risk: Exposure to uncertainty from U.S.-China relations, Ukraine war, Middle East conflict, Taiwan Strait tensions affecting operational costs and expansion
Financial SummaryXBRL
Revenue
$322M
Net Income
-$182M
Operating Margin
-55.3%
Net Margin
-56.6%
ROE
-126.7%
Total Assets
$217M
EPS (Diluted)
$-1.84
Operating Cash Flow
$34M
Source: XBRL data from DocGo Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on DocGo Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.